← Eichor
Study identifier: NCT07088874 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Novel Biomarkers and Postoperative Kidney Injury in Radical Nephrectomy

Condition: Nephrectomy · Acute Kidney Injury · Biomarker  ·  Sponsor: Peking University First Hospital

PhaseN/A
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The incidence of acute kidney injury (AKI) after radical nephrectomy exceeds 40%. Currently, the KDIGO criteria are the recognized diagnostic standard for AKI. These criteria primarily use serum creatinine and urine output as key indicators, but both parameters have certain limitations, such as delayed response, insensitivity, and inaccuracy. This study aims to simultaneously monitor perioperative novel renal damaging, stressful, and functional biomarkers in patients undergoing radical nephrectomy, and to investigate their predictive value for AKI and postoperative 1-year chronic kidney disease (CKD).

This description comes directly from the study's public registry record.

Talk to the study team

Qiongfang Wu, MD  ·  8610 83572460  ·  wuqf91@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Anesthesiology and Critical Care Medicine, Peking University First HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07088874